Neurology News

Healio Neurology’s five most-viewed stories in December highlight a study on increased sun exposure lowering children’s MS risk, FDA approval of a treatment for myasthenia gravis and research on a self-administered examination that may quickly identify mild cognitive impairment conversion to dementia.

Increasing asset limits placed on low-income Medicare beneficiaries seeking Medicaid supplemental coverage, which in many states have remained unchanged for 30 years, could increase eligibility by as much as 7.5%, according to researchers.

The FDA has granted fast track designation for lecanemab, an investigational antiamyloid beta protofibril antibody used for treatment of patients in the early stages of Alzheimer’s disease.

The American Academy of Neurology has updated a guideline for treating painful diabetic neuropathy using oral and topical treatments.

Parents commonly reported sleep concerns that persisted with age for children with early-life epilepsies, according to study results published in Pediatric Neurology.

Identifying and addressing risk factors for cognitive disorders shared within couples may reduce the risk for these disorders in the spouses of those with dementia, according to results of a prospective cohort study in JAMA Network Open.

The COVID-19 pandemic has put an enormous strain on health care workers and exacerbated existing burnout and staffing shortages. Many workers have reported considering leaving the profession altogether.

Occupational exposure to formaldehyde was detrimental to long-term cognitive function, according to results of a French cohort study published in Neurology.

Merck announced it has entered an agreement to acquire Chord Therapeutics, a biotech company that focuses on rare neuroinflammatory diseases, to expand its neurology pipeline.

Aimovig appeared safe and effective for treating migraine with and without history of aura, according to results of a secondary analysis of randomized clinical trials published in JAMA Neurology.